the current methods for treatment of cancers are inadequate and more specific methods such as gene therapy are in progress. among different vehicles, cationic liposomes are frequently used for delivery of genetic material. this investigation aims to prepare and optimize dotap cationic liposomes containing an antisense oligonuclotide (asodn) against protein kinase c alpha in non-small cells lung...

Background and Objective: Extracorporeal membrane oxygenation (ECMO) may be used as a substitute of traditional cardiopulmonary bypass (CPB) in thoracic surgeries. Extended resections for the treatment non-small cell lung cancer (NSCLC) occasionally require extracorporeal life support. We present narrative review current clinical uses devices this setting patients.

Current chemotherapy of advanced non-small cell lung cancer (NSCLC) produces only a modest increase in survival time. New approaches are needed for this disease. The development of lung cancer is associated with silencing tumor suppressor genes that can occur not only by deletion or mutation, but also by epigenetic changes including histone deacetylation of key lysines. Histone deacetylase inhi...

Lung cancer is treated with surgery, radiotherapy and chemotherapy according to histology and clinical stage. Advanced stage lung cancer patients cannot be cured, but early and locally-advanced stage patients can be cured by intensive combined-modality therapy. Combined-modality therapy with surgery plus adjuvant chemotherapy is standard for resectable IB-IIIA non-small cell lung cancer (NSCLC)...

-Lung cancer arises from abnormal epithelial cells in the airways of the lungs. Epithelial cells cover all free surfaces in the body including the airways. It is the most common cause of cancer-related death worldwide, owing to its metastatic spread at the time of diagnosis. Disease symptom management in patients with advanced non-small cell lung cancer (NSCLC) is a critical aspect of therapy. ...

Background: Endostatin and bevacizumab have been approved for the first-line treatment of advanced non-small-cell lung cancer (NSCLC) patients in China; however, clinical outcomes each drug combined with platinum-based doublet chemotherapy (PT-DC) not yet directly compared. This study sought to assess 2 drugs PT-DC adenocarcinoma.

In 2019, 70,000 people in the United States overdosed on opioids, with thousands more dependent these highly addictive substances.1 With recognition of opioid epidemic, physicians have been turning to alternative pain medications address cancer and treatment-related side effects. There are little data, however, guide care teams how best manage curative stages Non-Small Cell Lung Cancer (NSCLC)....

Non-small cell lung cancer (NSCLC) is the dominant form of cancer, comprising around 85% cases. Stage 4 NSCLC has a grim prognosis; however, immunotherapy and radiation therapy have become vital treatments for advanced-stage NSCLC, despite risk inducing second primary malignancy. This case report focuses on 45-year-old female diagnosed with metastasis to 11th thoracic vertebral body. After vari...